ArticleMolecular cancer therapeutics2022

The Irreversible FLT3 Inhibitor FF-10101 Is Active Against a Diversity of FLT3 Inhibitor Resistance Mechanisms.

Timothy T Ferng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.